GB0821693D0 - Therapeutic agents - Google Patents
Therapeutic agentsInfo
- Publication number
- GB0821693D0 GB0821693D0 GBGB0821693.9A GB0821693A GB0821693D0 GB 0821693 D0 GB0821693 D0 GB 0821693D0 GB 0821693 A GB0821693 A GB 0821693A GB 0821693 D0 GB0821693 D0 GB 0821693D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic agents
- therapeutic
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/36—Sulfur atom
- C07D473/38—Sulfur atom attached in position 6
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0821693.9A GB0821693D0 (en) | 2008-11-27 | 2008-11-27 | Therapeutic agents |
PCT/GB2009/002741 WO2010061180A1 (en) | 2008-11-27 | 2009-11-23 | Quinoline derivatives as p13 kinase inhibitors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0821693.9A GB0821693D0 (en) | 2008-11-27 | 2008-11-27 | Therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0821693D0 true GB0821693D0 (en) | 2008-12-31 |
Family
ID=40230932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0821693.9A Ceased GB0821693D0 (en) | 2008-11-27 | 2008-11-27 | Therapeutic agents |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0821693D0 (en) |
WO (1) | WO2010061180A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2137186T1 (en) * | 2007-03-23 | 2016-04-29 | Amgen Inc. | Heterocyclic compounds and their uses |
PT2139882E (en) | 2007-03-23 | 2014-01-30 | Amgen Inc | 3- substituted quinoline or quinoxaline derivatives and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors |
MX315904B (en) | 2008-05-30 | 2013-11-29 | Amgen Inc | Inhibitors of pi3 kinase. |
CN102625799A (en) | 2009-06-25 | 2012-08-01 | 安姆根有限公司 | Heterocyclic compounds and their uses |
EP2445902A2 (en) | 2009-06-25 | 2012-05-02 | Amgen, Inc | Heterocyclic compounds and their uses as inhibitors of pi3k activity |
US20100331306A1 (en) | 2009-06-25 | 2010-12-30 | Amgen Inc. | Heterocyclic compounds and their uses |
JP2012531435A (en) | 2009-06-25 | 2012-12-10 | アムジエン・インコーポレーテツド | 4H-pyrido [1,2-a] pyrimidin-4-one derivatives as PI3K inhibitors |
AU2010330875B2 (en) | 2009-12-18 | 2013-08-01 | Amgen Inc. | Heterocyclic compounds and their uses |
UY33304A (en) | 2010-04-02 | 2011-10-31 | Amgen Inc | HETEROCYCLIC COMPOUNDS AND THEIR USES |
CA2803619A1 (en) | 2010-06-30 | 2012-01-05 | Amgen Inc. | Heterocycle compounds and their uses |
CA2803259A1 (en) | 2010-07-01 | 2012-01-05 | Amgen Inc. | Heterocyclic compounds and their use as inhibitors of pi3k activity |
JP2013543000A (en) | 2010-11-17 | 2013-11-28 | アムジエン・インコーポレーテツド | Heterocyclic compounds and uses thereof |
US9637488B2 (en) * | 2015-01-29 | 2017-05-02 | Fuqiang Ruan | Heterocyclic compounds as inhibitors of class I PI3KS |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2137186T1 (en) * | 2007-03-23 | 2016-04-29 | Amgen Inc. | Heterocyclic compounds and their uses |
-
2008
- 2008-11-27 GB GBGB0821693.9A patent/GB0821693D0/en not_active Ceased
-
2009
- 2009-11-23 WO PCT/GB2009/002741 patent/WO2010061180A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2010061180A1 (en) | 2010-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0811304D0 (en) | Therapeutic agents | |
EP2117311A4 (en) | Therapeutic agents | |
GB0811643D0 (en) | New therapeutic agents | |
GB0908957D0 (en) | Therapeutic agents | |
GB0819593D0 (en) | Therapeutic agents | |
HRP20130041T8 (en) | Therapeutic agents | |
GB0821693D0 (en) | Therapeutic agents | |
GB0723747D0 (en) | Therapeutic agents | |
GB0812309D0 (en) | Therapeutic agents | |
GB0805818D0 (en) | Therapeutic agents | |
GB0801080D0 (en) | Therapeutic agents | |
GB0801081D0 (en) | Therapeutic agents | |
GB0724340D0 (en) | Novel Therapeutic Agents | |
EP2454276A4 (en) | Therapeutic agents | |
GB0723748D0 (en) | Therapeutic agents | |
GB0811715D0 (en) | Therapeutic agents | |
GB0910493D0 (en) | Therapeutic agents | |
GB0812558D0 (en) | Therapeutic agents | |
GB0815177D0 (en) | Therapeutic agents | |
GB0801082D0 (en) | Therapeutic agents | |
GB0820275D0 (en) | Therapeutic agents | |
GB0812563D0 (en) | Therapeutic agents | |
GB0815765D0 (en) | New therapeutic agents | |
GB0723749D0 (en) | Therapeutic agents | |
GB0725030D0 (en) | Therapeutic agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |